Skip to main content

Research Repository

Advanced Search

All Outputs (4)

Long-term topical corticosteroid use and risk of skin cancer: a systematic review (2018)
Journal Article
Ratib, S., Burden-Teh, E., Leonardi-Bee, J., Harwood, C., & Bath-Hextall, F. (in press). Long-term topical corticosteroid use and risk of skin cancer: a systematic review. JBI Database of Systematic Reviews and Implementation Reports, 16(6), https://doi.org/10.11124/jbisrir-2017-003393

Objective: The objective of this systematic review was to synthesize available research evidence to determine the risk of skin cancer in patients with long-term use of topical corticosteroids (TCS). Introduction: Topical corticosteroids are one of... Read More about Long-term topical corticosteroid use and risk of skin cancer: a systematic review.

Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis (2018)
Journal Article
Ban, L., Labbouz, S., Grindlay, D. J., Batchelor, J. M., & Ratib, S. (2018). Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis. British Journal of Dermatology, 179(4), 971-972. https://doi.org/10.1111/bjd.16703

Vitiligo is a chronic disorder causing skin depigmentation with around 1% global prevalence, affecting people of all ages, skin types and genders.1 Due to the absence of melanin in lesional skin there is a theoretical concern that there might be a hi... Read More about Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis.

How should minimally important change (MIC) scores for the Patient Oriented Eczema Measure (POEM) be interpreted?: a validation using varied methods (2018)
Journal Article
Howells, L., Ratib, S., Chalmers, J., Bradshaw, L., & Thomas, K. (2018). How should minimally important change (MIC) scores for the Patient Oriented Eczema Measure (POEM) be interpreted?: a validation using varied methods. British Journal of Dermatology, 178(5), https://doi.org/10.1111/bjd.16367

Background The Patient Oriented Eczema Measure (POEM), scored 0-28, is the core outcome instrument recommended for measuring patient-reported atopic eczema symptoms in clinical trials. To date, two published studies have broadly concurred that the... Read More about How should minimally important change (MIC) scores for the Patient Oriented Eczema Measure (POEM) be interpreted?: a validation using varied methods.